Isaac Collette is using his ongoing training at Brigham Young University with emphasis in business planning to help Glafabra identify and recruit venture capital. In this role, Isaac leverages his multi-year experience in investing in public equities and his role as Equity Analyst at Rogue Funds. Isaac also specifically focused on biotechnology sector and was responsible for bringing in Rogue Funds as Glafabra’s lead investor. As a result, he is currently serving on the Board of Directors for Glafabra as part of the investment agreement.